FURP.ORG / PUBLIC DATA EXPLORER

CRITICAL PATH INSTITUTE: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
CRITICAL PATH INSTITUTE (EIN 20-1991334)
Tax period
2021-07-01 to 2022-06-30
Filed
2023-04-07
IRS object ID
202330979349300518
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-04-07T11:41:57-05:00ReturnTs
Tax Period End2022-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN860683059PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1BEACHFLEISCHMAN PLLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line11985 E RIVER ROAD SUITE 201AddressLine1Txt
CityTUCSONCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85718ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2021-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN201991334EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CRITICAL PATH INSTITUTEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlCRITBusinessNameControlTxt
Phone5205473440PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11840 E RIVER ROAD 100AddressLine1Txt
CityTUCSONCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85718ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonKEVIN B PERKINSPersonNm
Person TitleCFOPersonTitleTxt
Phone5205473440PhoneNum
Signature2023-04-05SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstKEVINPersonFirstNm
Person LastPERKINSPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonKELLY L MELTZER CPAPreparerPersonNm
PTINP00633511PTIN
Phone5203214600PhoneNum
Preparation2023-04-05PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer3TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Address ChangeYes (X)AddressChangeInd
Principal OfficerDANIEL JORGENSENPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11840 E RIVER ROAD 100AddressLine1Txt
CityTUCSONCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85718ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$31,176,116GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressC-PATH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2004FormationYr
Legal Domicile StateAZLegalDomicileStateCd
Activity Or MissionINTERNATIONAL COLLABORATIONS AND NOVEL TOOLS TO ENABLE FASTER DEVELOPMENT OF SAFE MEDICAL PRODUCTSActivityOrMissionDesc
Voting Members Governing Body13VotingMembersGoverningBodyCnt
Voting Members Independent13VotingMembersIndependentCnt
Total Employee154TotalEmployeeCnt
Total Volunteers13TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$17,810,315PYContributionsGrantsAmt
CY Contributions Grants$23,061,454CYContributionsGrantsAmt
PY Program Service Revenue$6,610,023PYProgramServiceRevenueAmt
CY Program Service Revenue$8,108,029CYProgramServiceRevenueAmt
PY Investment Income$5,817PYInvestmentIncomeAmt
CY Investment Income$6,633CYInvestmentIncomeAmt
PY Other Revenue$942PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$24,427,097PYTotalRevenueAmt
CY Total Revenue$31,176,116CYTotalRevenueAmt
PY Grants And Similar Paid$3,294,397PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$4,230,463CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$14,630,286PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$17,392,416CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$5,080,822PYOtherExpensesAmt
CY Other Expenses$7,977,401CYOtherExpensesAmt
PY Total Expenses$23,005,505PYTotalExpensesAmt
CY Total Expenses$29,600,280CYTotalExpensesAmt
PY Revenues Less Expenses$1,421,592PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,575,836CYRevenuesLessExpensesAmt
Total Assets BOY$18,494,765TotalAssetsBOYAmt
Total Assets EOY$19,962,086TotalAssetsEOYAmt
Total Liabilities BOY$8,046,061TotalLiabilitiesBOYAmt
Total Liabilities EOY$7,937,546TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$10,448,704NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$12,024,540NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE CRITICAL PATH INSTITUTE IS A CATALYST IN THE DEVELOPMENT OF NEW APPROACHES THAT ADVANCE MEDICAL INNOVATION AND REGULATORY SCIENCE. THIS IS ACHIEVED BY LEADING TEAMS THAT SHARE DATA, KNOWLEDGE AND EXPERTISE RESULTING IN SOUND, CONSENSUS BASED SCIENCE.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$7,578,558ExpenseAmt
Grant$1,557,585GrantAmt
Revenue$0RevenueAmt
DescRARE DISEASE CURES ACCELERATOR-DATA AND ANALYTICS PLATFORM (RDCA-DAP) - SEE SCHEDULE ODesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$2,989,093ExpenseAmt
Grant$1,611,511GrantAmt
Revenue$0RevenueAmt
DescCURE DRUG REPURPOSING COLLABORATORY (CDRC) - SEE SCHEDULE ODesc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$1,713,473ExpenseAmt
Grant$239,633GrantAmt
Revenue$0RevenueAmt
DescREAL-WORLD DATA ANALYTICS PLATFORM (RW-DAP) - SEE SCHEDULE ODesc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$12,905,155ExpenseAmt
Grant$821,734GrantAmt
Revenue$8,108,029RevenueAmt
DescCRITICAL PATH INSTITUTE ALSO EXECUTES OTHER PROJECTS AND CONSORTIA IN AREAS INCLUDING THERAPEUTICS FOR THE ATAXIAS, POLYCYSTIC KIDNEY DISORDER, ALZHEIMER'S DISEASE, PARKINSON'S, TB, SICKLE CELL, TYPE ONE DIABETES, DUCHENNE MUSCULAR DYSTROPHY, MODEL INFORMED DRUG DEVELOPMENT, PATIENT-REPORTED OUTCOME, ELECTRONIC CLINICAL OUTCOME ASSESSMENT, RARE DISEASE CLINICAL OUTCOME ASSESSMENT, TRANSPLANT THERAPEUTICS, PREDICTIVE SAFETY TESTING, AND OTHERS.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$12,905,155TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$821,734TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$8,108,029TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$25,186,279TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (1)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document38IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee154EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial AccountYes (1)ForeignFinancialAccountInd
Foreign CountryEIForeignCountryCd
Foreign CountryNLForeignCountryCd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members13GoverningBodyVotingMembersCnt
Independent Voting Member13IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1KEVIN B PERKINS CFOBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone5206478382PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11840 E RIVER ROAD 100AddressLine1Txt
CityTUCSONCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85718ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (28 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
MR M WAINWRIGHT FISHBURN JR
CHAIRMAN1.00Yes (X)Yes (X)$0$0$0
MR JEFFERY JACOB
VICE CHAIRMAN1.00Yes (X)Yes (X)$0$0$0
DR TIMOTHY R FRANSON
BOARD MEMBER1.00Yes (X)$0$0$0
MS MARA G ASPINALL
BOARD MEMBER1.00Yes (X)$0$0$0
DR ROBERT M CALIFF
BOARD MEMBER1.00Yes (X)$0$0$0
MS KAY HOLCOMBE
BOARD MEMBER1.00Yes (X)$0$0$0
MR PETER BARTON HUTT
BOARD MEMBER1.00Yes (X)$0$0$0
MR SHAUN A KIRKPATRICK
BOARD MEMBER1.00Yes (X)$0$0$0
MR ALAN G LEVIN
BOARD MEMBER1.00Yes (X)$0$0$0
MR JAMES W NEWMAN
BOARD MEMBER1.00Yes (X)$0$0$0
DR PAULA J OLSIEWSKI
BOARD MEMBER1.00Yes (X)$0$0$0
DR TOMAS SALMONSON
BOARD MEMBER1.00Yes (X)$0$0$0
DR ALASTAIR JJ WOOD
BOARD MEMBER1.00Yes (X)$0$0$0
DR CRAIG BRATER
BOARD MEMBER1.00Yes (X)$0$0$0
MS KRISTEN SWINGLE
COO & INTERIM PRESIDENT40.00Yes (X)$307,667$0$39,060
MR KEVIN PERKINS
CHIEF FINANCIAL OFFICER & TREASURER40.00Yes (X)$85,373$0$10,431
MR LEWIS BARBIERI
CORPORATE SECRETARY40.00Yes (X)$129,328$0$21,660
MR RICHARD LIWSKI
CHIEF TECHNOLOGY OFFICER40.00$225,262$0$25,094Yes (X)
DR KLAUS ROMERO
CHIEF SCIENCE OFFICER40.00$250,697$0$32,919Yes (X)
DR SUDHIR SIVAKUMARAN
VICE PRESIDENT/EXECUTIVE DIRECTOR40.00$219,854$0$27,685Yes (X)
DR JOHN MICHAEL SAUER
SENIOR VICE PRESIDENT40.00$156,176$0$39,641Yes (X)
DR STEPHEN COONS
SENIOR VICE PRESIDENT40.00$217,922$0$28,464Yes (X)
DR JEFF BARRETT
SENIOR VICE PRESIDENT40.00$220,780$0$36,346Yes (X)
DR INISH O'DOHERTY
VICE PRESIDENT40.00$193,708$0$14,556Yes (X)
DR MARCO SCHITO
EXECUTIVE DIRECTOR40.00$183,386$0$27,703Yes (X)
DR DIANE STEPHENSON
EXECUTIVE DIRECTOR40.00$191,012$0$24,998Yes (X)
MS SONYA EREMENCO
EXECUTIVE DIRECTOR40.00$183,735$0$28,244Yes (X)
DR JOSEPH SCHEEREN
PRESIDENT & CEO THRU 03/19/2140.00$84,936$0$12,860Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,649,836TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$369,661TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K33IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (1)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmCountryContractorAddress/ForeignAddress/CountryCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCd
ARIDHIA INFORMATICS LIMITED
163 BATH STREETGLASGOWUKIT SERVICES$1,077,973
ROCHE DIAGNOSTICS OPERATIONS INC
RESEARCH SERVICES$525,0009115 HAGUE ROADINDIANAPOLISIN46250
TRIPLE POINTE HOLDINGS LLC
CONSULTANT$261,600378 PEAKHAM ROADSUDBURYMA01776
LOTOS NILE
PUBLIC RELATIONS$251,581PO BOX 90245NASHVILLETN37209
EPHIBIAN INC
IT SERVICE$173,3113180 N SWAN ROADTUCSONAZ85712
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K5CntrctRcvdGreaterThan100KCnt
Government Grants$16,906,032GovernmentGrantsAmt
All Other Contributions$6,155,422AllOtherContributionsAmt
Total Contributions$23,061,454TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
RESEARCH SUPPORT FEES541700$7,799,572$7,799,572
OTHER REVENUE900099$308,457$308,457
FieldValueIRS element (for citing)
Total Program Service Revenue$8,108,029TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$6,633TotalRevenueColumnAmt
Exclusion$6,633ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$31,176,116TotalRevenueColumnAmt
Related Or Exempt Func Income$8,108,029RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$6,633ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$3,914,930TotalAmt
Program Services$3,914,930ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$315,533TotalAmt
Program Services$315,533ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,929,659TotalAmt
Program Services$978,065ProgramServicesAmt
Management And General$951,594ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$12,444,580TotalAmt
Program Services$11,479,451ProgramServicesAmt
Management And General$965,129ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$899,761TotalAmt
Program Services$835,065ProgramServicesAmt
Management And General$64,696ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,091,459TotalAmt
Program Services$984,565ProgramServicesAmt
Management And General$106,894ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,026,957TotalAmt
Program Services$895,190ProgramServicesAmt
Management And General$131,767ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$52,510TotalAmt
Management And General$52,510ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$71,770TotalAmt
Management And General$71,770ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$3,750,908TotalAmt
Program Services$3,047,904ProgramServicesAmt
Management And General$703,004ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$325,459TotalAmt
Program Services$59,154ProgramServicesAmt
Management And General$266,305ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$290,140TotalAmt
Program Services$60,639ProgramServicesAmt
Management And General$229,501ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$2,229,778TotalAmt
Program Services$1,803,488ProgramServicesAmt
Management And General$426,290ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$599,614TotalAmt
Program Services$459,226ProgramServicesAmt
Management And General$140,388ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$190,740TotalAmt
Program Services$157,569ProgramServicesAmt
Management And General$33,171ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$209,651TotalAmt
Program Services$133,024ProgramServicesAmt
Management And General$76,627ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$34,813TotalAmt
Program Services$4,806ProgramServicesAmt
Management And General$30,007ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$89,009TotalAmt
Management And General$89,009ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
DUES AND SUBSCRIPTIONS$101,658$57,164$44,494
LOSS FROM SUBSIDIARY$20,144$20,144
MISCELLANEOUS$11,207$506$10,701

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$29,600,280TotalAmt
Program Services$25,186,279ProgramServicesAmt
Management And General$4,414,001ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$2,563,917BOYAmt
EOY$2,618,376EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$13,473,971BOYAmt
EOY$13,932,086EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,572,024BOYAmt
EOY$2,336,559EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$365,250BOYAmt
EOY$804,595EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$38,270BOYAmt
EOY$46,337EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$409,253LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$336,661LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$90,400BOYAmt
EOY$72,592EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$249,017BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$141,916BOYAmt
EOY$151,541EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$18,494,765BOYAmt
EOY$19,962,086EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,587,126BOYAmt
EOY$1,958,777EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$6,375,005BOYAmt
EOY$5,896,296EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$83,930BOYAmt
EOY$82,473EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$8,046,061BOYAmt
EOY$7,937,546EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$10,448,704BOYAmt
EOY$12,024,540EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,448,704BOYAmt
EOY$12,024,540EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$18,494,765BOYAmt
EOY$19,962,086EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$1,575,836ReconcilationRevenueExpnssAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$10,019,550CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$10,698,823CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$12,978,641CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$17,810,315CurrentTaxYearMinus1YearAmt
Current Tax Year$23,061,454CurrentTaxYearAmt
Total$74,568,783TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$10,019,550CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$10,698,823CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$12,978,641CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$17,810,315CurrentTaxYearMinus1YearAmt
Current Tax Year$23,061,454CurrentTaxYearAmt
Total$74,568,783TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$12,014,876SubstantialContributorsTotAmt
Public Support Total170$62,553,907PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$83,667CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$215,046CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$156,753CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$5,817CurrentTaxYearMinus1YearAmt
Current Tax Year$6,633CurrentTaxYearAmt
Total$467,916TotalAmt
FieldValueIRS element (for citing)
Total Support$75,036,699TotalSupportAmt
Gross Receipts Rltd Activities$31,096,324GrossReceiptsRltdActivitiesAmt
Public Support CY1700.83360PublicSupportCY170Pct
Public Support PY1700.71640PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$29,600,280FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$29,600,280FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$918,648CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$3,918,648TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$5,877,972LobbyingCeilingAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$229,662CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$979,662TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,469,493GrassrootsCeilingAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART II-A, LINE 1BFormAndLineReferenceDesc
ExplanationC-PATH DOES NOT LOBBY FOR OR AGAINST ANY SPECIFIC LEGISLATION. C-PATH DOES EXPEND A MODEST AMOUNT OF TIME AND MONEY TO EDUCATE LEGISLATORS AND THEIR STAFF IN THE AREA OF DRUG DEVELOPMENT.ExplanationTxt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$42,014OtherCostOrOtherBasisAmt
Depreciation$42,014DepreciationAmt
Book Value$0BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$136,750OtherCostOrOtherBasisAmt
Depreciation$129,263DepreciationAmt
Book Value$7,487BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$230,489OtherCostOrOtherBasisAmt
Depreciation$165,384DepreciationAmt
Book Value$65,105BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$72,592TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDEFERRED RENTDesc
Amt$82,473Amt
FieldValueIRS element (for citing)
Total Liability$82,473TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationFINANCIAL STATEMENT FIN 48 (ASC 740) FOOTNOTE: C-PATH IS EXEMPT FROM INCOME TAXES UNDER BOTH FEDERAL (INTERNAL REVENUE CODE SECTION 501(C)(3)) AND ARIZONA INCOME TAX LAWS, AND IS CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION UNDER INTERNAL REVENUE CODE SECTION 509(A)(1). INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO C-PATH'S TAX-EXEMPT PURPOSE, HOWEVER, MAY BE SUBJECT TO TAXATION AS UNRELATED BUSINESS TAXABLE INCOME (UBTI).ExplanationTxt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (4 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA (CANADA)00BUSINESS/VENDOR SERVICESIT SERVICES$17,955
EUROPE (FRANCE, GERMANY, SLOVENIA, SWEDEN, UNITED KINGDOM)00PROGRAM SERVICESCLINICAL RESEARCH, CONSULTING, LICENSING$2,070,750
EUROPE (UNITED KINGDOM)00GRANTS TO RECIPIENTS LOCATED IN REGIONCLINICAL RESEARCH$315,533
EUROPE (INCLUDING ICELAND & GREENLAND)00INVESTMENT-$14,752
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$2,389,486SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$2,389,486TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionEUROPE (INCLUDING ICELAND & GREENLAND)RegionTxt
Purpose Of GrantSUBAWARDPurposeOfGrantTxt
Cash Grant$315,533CashGrantAmt
Manner Of Cash DisbursementWIRE TRANSFERMannerOfCashDisbursementTxt
Non Cash Assistance$0NonCashAssistanceAmt
FieldValueIRS element (for citing)
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign TrustYes (1)InterestInForeignTrustInd
Foreign Corp OwnershipYes (1)ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:CRITICAL PATH INSTITUTE ENTERS INTO SUBAWARD AGREEMENTS WITH SUBRECIPIENTS AND REVIEWS PROGRESS DELIVERABLES AND COSTS.
PART III ACCOUNTING METHOD:

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (12 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxt
NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD)
1900 CROWN COLONY DRIVE SUITE 310QUINCYMA02169133223946501(C)(3)$1,604,706$0SUBAWARD
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905416011702501(C)(3)$132,270$0SUBAWARD
JAEB CENTER FOR HEALTH RESEARCH
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647593187624501(C)(3)$28,251$0SUBAWARD
TUFTS MEDICAL CENTER INC
800 WASHINGTON STREET RF BOX 453BOSTONMA02111043400617501(C)(3)$101,895$0SUBAWARD
INSTITUTE FOR ADVANCED CLINICAL TRIALS FOR CHILDREN
9211 CORPORATE BLVD SUITE 260ROCKVILLEMD20850812076517501(C)(3)$137,738$0SUBAWARD
NORTHWESTERN UNIVERSITY
633 CLARK STREET ROOM G-547EVANSTONIL60208362167817501(C)(3)$45,364$0SUBAWARD & RESEARCH
SOCIETY OF CRITICAL CARE MEDICINE
35083 EAGLE WAYCHICAGOIL60678237104387501(C)(3)$835,334$0SUBAWARD
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVECHICAGOIL60693520595110501(C)(3)$263,051$0SUBAWARD
EMORY UNIVERSITY
1599 CLIFTON ROAD NE 4TH FLOORATLANTAGA30322580566256501(C)(3)$314,286$0SUBAWARD
UNIVERSITY OF ROCHESTER
265 CRITTENDEN BLVD CU420694ROCHESTERNY14642160743209501(C)(3)$186,530$0SUBAWARD
THE REGENTS OF THE UNIV OF MICHIGAN
1000 VICTORS WAY SUITE 1AANN ARBORMI48108386006309501(C)(3)$183,750$0SUBAWARD
RUTGERS THE STATE UNIVERSITY
33 KNIGHTBRIDGE RD 2ND FL EASTPISCATAWAYNJ08854226001086501(C)(3)$81,755$0SUBAWARD
FieldValueIRS element (for citing)
Total501c3 Org12Total501c3OrgCnt
Total Other Org12TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationCRITICAL PATH INSTITUTE ENTERS INTO SUBAWARD AGREEMENTS WITH SUBRECIPIENTS AND REVIEWS PROGRESS DELIVERABLES AND COSTS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (13 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
MS KRISTEN SWINGLE
COO & INTERIM PRESIDENT$281,092$0$26,575$0$0$0$21,334$0$17,726$0$346,727$0$0$0
DR KLAUS ROMERO
CHIEF SCIENCE OFFICER$224,684$0$26,013$0$0$0$19,728$0$13,191$0$283,616$0$0$0
DR JEFF BARRETT
SENIOR VICE PRESIDENT$204,176$0$16,604$0$0$0$18,631$0$17,715$0$257,126$0$0$0
MR RICHARD LIWSKI
CHIEF TECHNOLOGY OFFICER$203,658$0$21,604$0$0$0$17,538$0$7,556$0$250,356$0$0$0
DR SUDHIR SIVAKUMARAN
VICE PRESIDENT/EXECUTIVE DIRECTOR$198,953$0$20,901$0$0$0$17,787$0$9,898$0$247,539$0$0$0
DR STEPHEN COONS
SENIOR VICE PRESIDENT$201,236$0$16,686$0$0$0$16,929$0$11,535$0$246,386$0$0$0
DR DIANE STEPHENSON
EXECUTIVE DIRECTOR$183,586$0$7,426$0$0$0$12,012$0$12,986$0$216,010$0$0$0
MS SONYA EREMENCO
EXECUTIVE DIRECTOR$176,395$0$7,340$0$0$0$15,267$0$12,977$0$211,979$0$0$0
DR MARCO SCHITO
EXECUTIVE DIRECTOR$171,856$0$11,530$0$0$0$14,783$0$12,920$0$211,089$0$0$0
DR INISH O'DOHERTY
VICE PRESIDENT$179,398$0$14,310$0$0$0$13,550$0$1,006$0$208,264$0$0$0
DR JOHN MICHAEL SAUER
SENIOR VICE PRESIDENT$156,176$0$0$0$0$0$29,290$0$10,351$0$195,817$0$0$0
MR LEWIS BARBIERI
CORPORATE SECRETARY$124,310$0$5,018$0$0$0$10,439$0$11,221$0$150,988$0$0$0
DR JOSEPH SCHEEREN
PRESIDENT & CEO THRU 03/19/21$84,936$0$0$0$0$0$9,442$0$3,418$0$97,796$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 7FormAndLineReferenceDesc
ExplanationCRITICAL PATH AWARDS VARIABLE COMPENSATION BASED ON PERFORMANCE AND WITH GUIDANCE FROM THE COMPENSATION COMMITTEE.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICESTHE RARE DISEASE CURES ACCELERATOR-DATA AND ANALYTICS PLATFORM (RDCA-DAP) IS AN FDA-FUNDED INITIATIVE THAT PROVIDES A CENTRALIZED AND STANDARDIZED INFRASTRUCTURE TO SUPPORT AND ACCELERATE RARE DISEASE CHARACTERIZATION, WITH THE GOAL OF ACCELERATING THERAPY DEVELOPMENT ACROSS RARE DISEASES. THIS PLATFORM IS MADE POSSIBLE THROUGH A COLLABORATIVE GRANT FROM THE FDA AND IN PARTNERSHIP WITH THE NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD). RDCA-DAP PROMOTES THE SHARING OF EXISTING PATIENT-LEVEL DATA AND ENCOURAGES THE STANDARDIZATION OF NEW DATA COLLECTION. BY INTEGRATING SUCH DATA IN A REGULATORY-GRADE FORMAT SUITABLE FOR ANALYTICS, RDCA- DAP ACCELERATES THE UNDERSTANDING OF DISEASE PROGRESSION (INCLUDING SOURCES OF VARIABILITY TO OPTIMIZE THE CHARACTERIZATION OF SUBPOPULATIONS), CLINICAL OUTCOME MEASURES AND BIOMARKERS, AND FACILITATES THE DEVELOPMENT OF MATHEMATICAL MODELS OF DISEASE AND INNOVATIVE CLINICAL TRIAL DESIGNS. RDCA-DAP IS POSITIONED TO GENERATE SOLUTIONS TO DRUG DEVELOPMENT BOTTLENECKS. ACCOMPLISHMENTS THIS YEAR INCLUDE: (1) SIGNED 24 DATA CONTRIBUTION AGREEMENTS (DCAS), TWELVE MOUS AND THIRTEEN NDAS NEGOTIATED AND SIGNED TO DATE TO DATE; (2) THE RDCA-DAP PLATFORM CURRENTLY INCLUDES OVER 75 RARE DISEASE DATA SETS REPRESENTING 25 DISEASE STATES FROM 53,001 PATIENTS; (3) MANUSCRIPT, "INNOVATIONS IN THERAPY DEVELOPMENT FOR RARE DISEASES THROUGH THE RARE DISEASE CURES ACCELERATOR DATA AND ANALYTICS PLATFORM," SUBMITTED TO THERAPEUTIC INNOVATION & REGULATORY SCIENCE COMPLETED AND PUBLISHED WHITE PAPER ON RDCA-DAP WEBSITE TITLED "RARE DISEASES CURES ACCELERATOR DATA AND ANALYTICS PLATFORM (RDCA-DAP) BEST PRACTICES AND RECOMMENDATIONS FOR FAIR DATA, TOWARD ALIGNMENT WITH INTERNATIONAL REGULATORY AGENCIES," SHARING LESSONS LEARNED FOR STORING AND SHARING DATA AND STRATEGIES FOR COLLECTING REGISTRY DATA THAT WILL MAXIMIZE IMPACT ON THE DRUG AND DIAGNOSTIC TOOLS ECOSYSTEM; (4) TECHNICAL ADVISORY GROUP MEETING HELD WITH FDA AND NORD TO DEMONSTRATE THE PLATFORM TO A WIDER FDA AUDIENCE.
FORM 990, PART III, LINE 4B, DESCRIPTION OF PROGRAM SERVICESTHE GOAL OF THE CURE DRUG REPURPOSING COLLABORATORY (CDRC) IS TO BE THE CENTRAL GLOBAL SOURCE OF VALIDATED REAL-WORLD DATA OF REPURPOSED DRUGS FOR DISEASES WITH THE HIGHEST LEVELS OF UNMET MEDICAL NEED. TO ACCOMPLISH THIS GOAL, CDRC IS WORKING WITH MULTIPLE STAKEHOLDERS TO DEVELOP OPEN-SOURCED TOOLS TO AUTOMATE THE EXTRACTION, AGGREGATION, ANALYSIS AND SHARING OF KEY CLINICAL DATA ELEMENTS FROM ELECTRONIC HEALTH RECORDS IN A DEIDENTIFIED MANNER REGARDLESS OF THE VENDOR OR DATA MODEL FOR IDENTIFYING FDA APPROVED DRUGS PRESCRIBED FOR NEW INDICATIONS. IN ADDITION, CDRC IS WORKING TO DEVELOP A WEB-BASED PATIENT PORTAL FOR PATIENTS TO PROVIDE THEIR TREATMENT JOURNEY EXPERIENCE TO ALLEVIATE SYMPTOMS OF DISEASE THAT IS NOT ON THE CURRENT DRUG LABEL OR AMELIORATE SIDE EFFECTS OF EXISTING FDA APPROVED AND PRESCRIBED TREATMENTS. THE ANALYSIS OF REAL-WORLD DATA FROM BOTH CLINICIANS AND PATIENTS WILL BE USED TO GENERATE HYPOTHESIS THAT CAN SUPPLEMENT EXISTING CLINICAL TRIAL DATA OR INFORM CLINICAL TRIAL DESIGN IN HOW EXISTING FDA APPROVED DRUGS CAN BE EVALUATED IN RANDOMIZED TRIALS TO ASSESS TREATMENT EFFICACY. THE UTILITY OF SYSTEMATICALLY COLLECTING EXISTING REAL-WORLD DATA TO GENERATE REAL-WORLD EVIDENCE AND LINKAGE TO CLINICAL TRIALS WILL HELP INFORM PRESCRIBERS HOW TO MAXIMIZE THE USE OF EXISTING FDA APPROVED DRUGS AND LEVERAGE EXISTING DATA TO CHANGE CLINICAL PRACTICE AND HELP ADDRESS THE HIGH UNMET CLINICAL NEED OF PATIENTS WITH DISEASES THAT HAVE LITTLE OR NO TREATMENT OPTIONS. ACCOMPLISHMENTS THIS YEAR INCLUDE: (1) DESIGNED AND CONSTRUCTED A BIOINFORMATIC DATA PROCESSING PIPELINE IN AMAZON WEB SERVICES (AWS) TO DIGEST DATA FROM CURE ID AND GENERATE INFORMATIVE INSIGHTS FOR DRUG REPURPOSING; (2) DEFINED RARE DISEASE PILOTS FOR ONCOLOGY (SARCOMA SUBTYPES: ANGIOSARCOMA, PERIVASCULAR EPITHELIOID CELL TUMORS AND EPITHELIOID HEMANGIOENDOTHELIOMA) AND NON-ONCOLOGY (RASOPATHIES WITH THE EXCEPTION OF NEUROFIBROMATOSIS TYPE 1), ENGAGED CLINICAL EXPERTS TO REVIEW AND DEFINE DATA ELEMENTS, ESTABLISHED DRUG REPURPOSING TASK FORCE WITH PATIENT GROUPS; (3) SECURED FUNDING FOR CREATE FROM THREE PHARMA COMPANIES WHO EXPECT TO COME TO MARKET SOON WITH NEW PRODUCTS FOR IBD BUT THE PROJECT REQUIRES ADDITIONAL INVESTMENT TO BUILD THE REGISTRY INFRASTRUCTURE; (4) FINALIZED PROTOCOL SYNOPSIS AND IDENTIFIED PILOT SITES (BAYLOR, HOPKINS AND UAB) FOR SECURING CONGENITAL CMV DATA FROM EHRS; (5) SUCCESSFULLY UPLOADED COVID-19 DATA AUTOMATICALLY EXTRACTED FROM EHR FROM FIRST PILOT SITE TO C-PATH USING THE EDGE TOOL; (6) ESTABLISHED WHO COLLABORATION ON SEXUALLY TRANSMITTED INFECTION TREATMENT FAILURES FOR GONORRHEA AND MYCOPLASMA GENETALIUM.
FORM 990, PART III, LINE 4C, DESCRIPTION OF PROGRAM SERVICESTHE OBJECTIVES OF C-PATH'S REAL-WORLD DATA ANALYTICS PLATFORM (RW-DAP) PROJECT ARE TO ASSIMILATE CLINICAL TRIAL DATASETS, ELECTRONIC HEALTH RECORDS (EHR), AND REGISTRY DATA FROM GLOBAL PARTNERS AND GENERATE ACTIONABLE SOLUTIONS TO ACCELERATE DRUG DEVELOPMENT IN NEONATOLOGY. THIS PROJECT ENTAILS GENERATING A REAL-WORLD DATA ANALYTICS PLATFORM (RW-DAP) THAT WILL AGGREGATE, STANDARDIZE, AND INTEGRATE PATIENT-LEVEL REAL WORLD DATA (RWD) TO (1) ESTABLISH NEONATAL LABORATORY VALUE REFERENCE RANGES BY GESTATIONAL AND POSTNATAL AGE, AND OTHER PATIENT-LEVEL CHARACTERISTICS, AND (2) DEVELOP A QUANTITATIVE DISEASE PROGRESSION MODEL FOR BRONCHOPULMONARY DYSPLASIA (ONE OF THE MOST CHALLENGING RESPIRATORY COMPLICATIONS OF PREMATURITY). ANY GAPS THAT INTERFERE WITH OPTIMAL USE OF EXISTING RWD WILL BE IDENTIFIED, AND SOLUTIONS THAT WILL IMPROVE THE USABILITY OF RWD IN THE FUTURE WILL BE PROPOSED. DURING THE PAST ONE YEAR, WE HAVE CONTINUED TO MEET AND MAKE SIGNIFICANT PROGRESS WITH PHARMACEUTICAL COMPANIES, ACADEMIC INSTITUTES, AND NEONATAL REGISTRY NETWORKS FOR THE PROJECT. DISCUSSIONS HAVE BEEN ONGOING WITH 22 ACADEMIC INSTITUTES WHO HAVE INDICATED A WILLINGNESS TO COLLABORATE WITH US. IN AGGREGATE, C-PATH HAS RECEIVED DATASETS REPRESENTING >200,000 PATIENTS AND EXPECTS 100,000 ADDITIONAL PATIENTS IN FUTURE DATASETS WITH PARTNERS AND COLLABORATORS. IN ORDER TO FOCUS AND LEVERAGE THE EXPERIENCE AND EXPERTISE OF THE LARGE INC STAKEHOLDER NETWORK, WE HAVE CREATED BPD AND LABORATORY VALUE WORKGROUPS. THE BPD WORKGROUP HAS 30 MEMBERS, COMPRISED OF ACADEMIC, INDUSTRY, AND REGULATORY RESEARCHERS WITH EXPERTISE IN BPD RESEARCH AS WELL AS PARENT MEMBERS. THE LABORATORY VALUE WORKGROUP HAS 20 MEMBERS, COMPRISED OF ACADEMIC AND INDUSTRY RESEARCHERS WHO HAVE A LONGSTANDING INTEREST IN CREATING GENERALIZABLE REFERENCE RANGES FOR LABORATORY VALUES IN NEONATES.
FORM 990, PART VI, SECTION A, LINE 2PETER HUTT AND JEFF JACOB HAVE A BUSINESS RELATIONSHIP. WAIN FISHBURN AND JEFF JACOB HAVE A BUSINESS RELATIONSHIP. JEFF JACOB AND SHAUN KIRKPATRICK HAVE A BUSINESS RELATIONSHIP. TOMAS SALMONSON AND JEFF JACOB HAVE A BUSINESS RELATIONSHIP.
FORM 990, PART VI, SECTION B, LINE 11BFORM 990 IS PREPARED BY AN EXTERNAL CPA FIRM USING INFORMATION PROVIDED BY THE ORGANIZATION. THE FORM IS REVIEWED BY THE ORGANIZATION'S CFO, PRESIDENT/COO, CEO, THE BOARD AUDIT, FINANCE, AND RISK COMMITTEE, AND THE BOARD OF DIRECTORS PRIOR TO BEING FINALIZED.
FORM 990, PART VI, SECTION B, LINE 12CALL MEMBERS OF THE BOARD OF DIRECTORS AND ALL OFFICERS OF THE ORGANIZATION ARE REQUIRED TO FILL OUT A CONFLICT OF INTEREST FORM ANNUALLY. THE RESULTS ARE COMPILED AND REVIEWED BY THE BOARD'S AUDIT, FINANCE, AND RISK COMMITTEE. ANY ACTUAL OR PERCEIVED CONFLICTS THAT HAVE THE POTENTIAL TO BIAS ANY DISCUSSIONS OR DECISIONS BY THE BOARD ARE DISCUSSED BY THE BOARD. ANY DIRECTOR WITH A REAL OR POTENTIAL CONFLICT WILL RECUSE THEMSELVES FROM ANY DISCUSSION OR DECISION WHERE THE CONFLICT HAS A BEARING.
FORM 990, PART VI, SECTION B, LINE 15A BOARD OF DIRECTORS COMPENSATION COMMITTEE MEETS AND REVIEWS EXECUTIVE COMPENSATION ANNUALLY. PERIODICALLY, THE COMMITTEE REQUESTS A COMPENSATION ANALYSIS TO DETERMINE IF EMPLOYEE COMPENSATION HAS REMAINED WITHIN MARKET RANGE OR IF ADJUSTMENTS ARE REQUIRED. THIS INFORMATION IS THEN USED AS A BASIS FOR THE COMPENSATION COMMITTEE'S RECOMMENDATION TO THE BOARD OF DIRECTORS. AN OVERALL SALARY PROGRAM FOR EMPLOYEES MUST BE APPROVED BY THE BOARD OF DIRECTORS COMPENSATION COMMITTEE BEFORE IMPLEMENTATION. ALL EMPLOYEE SALARY INCREASES MUST BE APPROVED BY THE PRESIDENT/COO.
FORM 990, PART VI, SECTION C, LINE 19ARTICLES OF INCORPORATION CAN BE FOUND ON THE ARIZONA CORPORATION COMMISSION WEBSITE. THE CONFLICT OF INTEREST POLICY AND THE FINANCIAL STATEMENTS (VIA THE ANNUAL REPORT) ARE POSTED ON THE INSTITUTE'S WEBSITE.
FORM 990, PART IX, LINE 11GRESEARCH SUPPORT SERVICES: PROGRAM SERVICE EXPENSES 1,481,156. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,481,156. CONSULTING: PROGRAM SERVICE EXPENSES 1,166,698. MANAGEMENT AND GENERAL EXPENSES 415,577. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,582,275. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 400,050. MANAGEMENT AND GENERAL EXPENSES 287,427. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 687,477.

Schedule R IRS990ScheduleR

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)

Address Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile Foreign CountryLegalDomicileForeignCountryCdBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtEntity TypeEntityTypeTxtShare Of EOY AssetsShareOfEOYAssetsAmtOwnershipOwnershipPctControlled OrganizationControlledOrganizationInd
CRITICAL PATH INSTITUTE LTD
33 SIR JOHN ROGERSONS QUAYDUBLINEIEDUCATION AND RESEARCH IN EUROPE TO ACCELERATE DEVELOPMENT OF NEW THERAPIESEICRITICAL PATH INSTITUTEC$321,0531.00000Yes (1)
CRITICAL PATH INSTITUTE STICHTING
1083 HN AMSTERDAMAMSTERDAMNLEDUCATION AND RESEARCH IN EUROPE TO ACCELERATE DEVELOPMENT OF NEW THERAPIESNLCRITICAL PATH INSTITUTETYes (1)
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgYes (1)LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp

Other Organization Name OtherOrganizationName

FieldValueIRS element (for citing)
Business Name Line1CRITICAL PATH INSTITUTE LTDBusinessNameLine1Txt
FieldValueIRS element (for citing)
Transaction TypeDTransactionTypeTxt
Involved$156,320InvolvedAmt
Method Of Amount DeterminationEND OF YEAR BALANCEMethodOfAmountDeterminationTxt